Results 151 to 160 of about 42,414 (275)

Certification of the industry reference standard for the specific activity of «BiVac polio» - live attenuated bivalent oral polio vaccine type 1 and 3

open access: yesБиопрепараты: Профилактика, диагностика, лечение, 2018
The standardization and control of «BiVac polio» (live attenuated bivalent oral polio vaccine type 1 and 3) developed by M. P. Chumakov Institute of Poliomyelitis and Viral Encephalitides of the Russian Academy of Medical Sciences, called for ...
E. V. Karpova   +6 more
doaj  

Bibliography on inactivation of viruses and rickettsiae by heat [PDF]

open access: yes
Inactivation of viruses and rickettsiae by heat ...
Homann, L. M., Watson, M. S.
core   +1 more source

Eradikasi dan Babak Akhir Polio: Peran Tenaga Kesehatan Indonesia [PDF]

open access: yes, 2016
Poliomielitis adalah penyakit menular yangditandai dengan kelumpuhan akibat kerusakanmotor neuron di kornu anterior sumsum tulangbelakang; disebabkan oleh tiga serotipe virus polioyaitu serotipe 1 (brunhilde), serotipe 2 (lansig) danserotipe 3 (leon).1 ...
Gunardi, H. (Hartono)
core  

Viral Aetiology of Acute Flaccid Paralysis Surveillance Cases, before and after Vaccine Policy Change from Oral Polio Vaccine to Inactivated Polio Vaccine

open access: yesJournal of Tropical Medicine, 2014
Since 1992, surveillance for acute flaccid paralysis (AFP) cases was introduced in Malaysia along with the establishment of the National Poliovirus Laboratory at the Institute for Medical Research.
T. S. Saraswathy Subramaniam   +4 more
doaj   +1 more source

Evaluation and validation of next-generation sequencing to support lot release for a novel type 2 oral poliovirus vaccine

open access: yesVaccine: X, 2021
John O. Konz   +15 more
semanticscholar   +1 more source

Novel Oral Polio Vaccine Type 2 Use for Polio Outbreak Response: A Global Effort for a Global Health Emergency

open access: yesPathogens
A sharp rise in circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreaks in the years following the cessation of routine use of poliovirus type 2-containing oral polio vaccine and the trend of seeding new emergences with suboptimal vaccination ...
Feyrouz Damji Kurji   +9 more
doaj   +1 more source

Impediments to Progress Toward Polio Eradication During 2014–2024: Effectively Addressing the Current Challenges

open access: yesVaccines
When the Global Polio Eradication Initiative (GPEI) began in 1988, the year 2000 target was clearly ambitious. Nonetheless, among 20 countries with endemic wild poliovirus transmission in 2000, only Afghanistan, Nigeria and Pakistan remained endemic in ...
Steven G. F. Wassilak   +2 more
doaj   +1 more source

Serodifferentiation of Poliovirus Strains for Studies of Oral Vaccine [PDF]

open access: yesPublic Health Reports (1896-1970), 1962
Henry M. Gelfand   +2 more
openaire   +3 more sources

Antiviral Development for the Polio Endgame: Current Progress and Future Directions

open access: yesPathogens
As the world is approaching the eradication of wild poliovirus serotype 1, the last of the three wild types, the question of how to maintain a polio-free world becomes imminent.
Hang Xie   +6 more
doaj   +1 more source

Rare adverse events associated with oral poliovirus vaccine in Brazil

open access: yesBrazilian Journal of Medical and Biological Research, 1997
Oral poliovirus vaccine (OPV) developed by A. Sabin has been effectively used to control poliomyelitis in Brazil, and the last case with the isolation of a wild poliovirus strain occurred in March 1989.
Friedrich F.
doaj  

Home - About - Disclaimer - Privacy